CD207
Basic information
Region (hg38): 2:70830211-70835816
Links
Phenotypes
GenCC
Source:
- Birbeck granule deficiency (No Known Disease Relationship), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Birbeck granule deficiency | AD | General | The condition may not involve clinical relevance | General | The clinical relevance of the condition is unclear |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD207 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 24 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 5 | 10 |
Variants in CD207
This is a list of pathogenic ClinVar variants found in the CD207 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-70831053-C-T | CD207-related disorder | Benign (Oct 21, 2019) | ||
2-70831057-T-G | not specified | Uncertain significance (Dec 09, 2023) | ||
2-70831070-A-G | not specified | Uncertain significance (May 25, 2022) | ||
2-70831075-C-A | not specified | Uncertain significance (Aug 17, 2021) | ||
2-70831075-C-T | not specified | Uncertain significance (Mar 13, 2023) | ||
2-70831095-C-T | CD207-related disorder | Benign (Oct 18, 2019) | ||
2-70831156-T-G | not specified | Uncertain significance (Feb 05, 2024) | ||
2-70831177-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
2-70831189-G-A | not specified | Uncertain significance (Oct 14, 2023) | ||
2-70831704-A-G | CD207-related disorder | Benign (Oct 17, 2019) | ||
2-70831719-T-C | not specified | Uncertain significance (May 14, 2024) | ||
2-70831728-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
2-70831747-A-G | Birbeck granule deficiency | Uncertain significance (Apr 04, 2024) | ||
2-70831794-C-A | not specified | Uncertain significance (Jun 30, 2023) | ||
2-70831800-G-A | not specified | Uncertain significance (Aug 16, 2021) | ||
2-70832906-A-G | CD207-related disorder | Benign (Nov 06, 2019) | ||
2-70832986-G-C | not specified | Uncertain significance (Dec 26, 2023) | ||
2-70833009-T-G | not specified | Uncertain significance (May 24, 2024) | ||
2-70833033-A-G | not specified | Uncertain significance (Nov 28, 2023) | ||
2-70833044-A-C | not specified | Uncertain significance (May 31, 2023) | ||
2-70833651-C-T | not specified | Likely benign (Jun 02, 2023) | ||
2-70833685-C-T | not specified | Likely benign (May 04, 2022) | ||
2-70833699-A-G | not specified | Uncertain significance (May 10, 2023) | ||
2-70833805-G-C | CD207-related disorder | Benign (Oct 21, 2019) | ||
2-70833809-G-A | Birbeck granule deficiency | Uncertain significance (Mar 30, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD207 | protein_coding | protein_coding | ENST00000410009 | 6 | 5606 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000282 | 0.541 | 650 | 123989 | 2 | 124641 | 0.928 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0171 | 177 | 178 | 0.996 | 0.00000973 | 2130 |
Missense in Polyphen | 45 | 43.317 | 1.0389 | 592 | ||
Synonymous | -0.280 | 74 | 71.0 | 1.04 | 0.00000414 | 624 |
Loss of Function | 0.797 | 10 | 13.1 | 0.762 | 6.43e-7 | 160 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 2.01 | 1.90 |
Ashkenazi Jewish | 1.00 | 0.939 |
East Asian | 1.01 | 0.933 |
Finnish | 1.00 | 0.933 |
European (Non-Finnish) | 1.00 | 0.931 |
Middle Eastern | 1.01 | 0.933 |
South Asian | 1.00 | 0.928 |
Other | 1.00 | 0.921 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-dependent lectin displaying mannose-binding specificity. Induces the formation of Birbeck granules (BGs); is a potent regulator of membrane superimposition and zippering. Binds to sulfated as well as mannosylated glycans, keratan sulfate (KS) and beta-glucans. Facilitates uptake of antigens and is involved in the routing and/or processing of antigen for presentation to T cells. Major receptor on primary Langerhans cells for Candida species, Saccharomyces species, and Malassezia furfur. Protects against human immunodeficiency virus-1 (HIV-1) infection. Binds to high-mannose structures present on the envelope glycoprotein which is followed by subsequent targeting of the virus to the Birbeck granules leading to its rapid degradation. {ECO:0000269|PubMed:10661407, ECO:0000269|PubMed:17334373, ECO:0000269|PubMed:20026605, ECO:0000269|PubMed:20097424}.;
- Disease
- DISEASE: Birbeck granule deficiency (BIRGD) [MIM:613393]: A condition characterized by the absence of Birbeck granules in epidermal Langerhans cells. Despite the lack of Birbeck granules, Langerhans cells are present in normal numbers and have normal morphologic characteristics and antigen-presenting capacity. {ECO:0000269|PubMed:15816828, ECO:0000269|PubMed:16567809}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Cross-presentation of soluble exogenous antigens (endosomes)
(Consensus)
Recessive Scores
- pRec
- 0.160
Haploinsufficiency Scores
- pHI
- 0.0381
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.470
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.125
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Cd207
- Phenotype
- immune system phenotype; hematopoietic system phenotype; respiratory system phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;receptor-mediated endocytosis;defense response to virus
- Cellular component
- plasma membrane;integral component of membrane;endocytic vesicle;clathrin-coated endocytic vesicle membrane;early endosome membrane
- Molecular function
- protein binding;mannose binding;carbohydrate binding